Le Lézard
Classified in: Health
Subjects: SVY, POL, PSF, STP

Representative Bahr Lauds the Accomplishments of NPLEx in the First Quarter of 2015



JEFFERSON CITY, Mo., June 29, 2015 /PRNewswire/ -- Missouri State Representative Kurt Bahr (R-O'Fallon) today released the 2015 first quarter data from the state's real-time, stop-sale system, known as the National Precursor Log Exchange (NPLEx).

States across the United States are using NPLEx, making Missouri one of 31 across the country that currently utilize the system to automatically block unlawful, attempted pseudoephedrine (PSE) purchases at the point of sale.  NPLEx aids retailers and law enforcement officers as they work together to seek to stop criminals from purchasing medicine containing PSE and attempt to divert the decongestant to meth. NPLEx has played a vital role across the country limiting the illegal sale of PSE and stopping domestic meth production.

During the first quarter of 2015, the NPLEx system in Missouri helped block the sale of 4,390 boxes of PSE, keeping 11,401 grams from being used illegally.

"In the first quarter of 2015, NPLEx again proved that it is an important tool for law officers in their fight against meth," said Representative Bahr. "Our state has seen a decline in domestic meth production in recent years as meth criminals find it harder to make the drug. This does not mean the fight is over. Missouri must fight the increasing amount of meth coming in from Mexico as drug cartels replace what previously had been domestically produced. I have no doubt that our state will stand up to this drug and continue to make sure our addicts our treated, while maintaining law-abiding citizens' access to cold and allergy medications containing PSE."

SOURCE Missouri State Representative Kurt Bahr


These press releases may also interest you

at 13:00
Orig3n, a Boston-based biotech company pioneering the future of health through genetics and regenerative medicine, today announced that its co-founders, Robin Y. Smith, CEO, and Kate Blanchard, COO, are finalists for the Ernest and Young Entrepreneur...

at 13:00
The "Infantile Spasms Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global infantile spasms therapeutics market to...

at 13:00
Members of the Union of Canadian Correctional Officers (UCCO-SACC-CSN) will be demonstrating on Monday, June 25, in front of the office of Ginette Petitpas Taylor, Canada's Minister of Health. The correctional officers are asking the government to...

at 13:00
Mezzion Pharma and the National Heart, Lung, and Blood Institute (NHLBI) today announced that it has completed enrollment of their FUEL trial, a pivotal Phase 3 efficacy and safety trial of udenafil for the treatment of adolescents with congenital...

at 12:51
Unable to carry signals based on sights and sounds to the genes that record memories, a broken shuttle protein may hinder learning in patients with intellectual disability, schizophrenia, and autism. This is the...

at 12:47
FSD Pharma Inc. ("FSD" or the "Company") , welcomes the official passing of Bill C-45, the Cannabis Act in Canada. Bill C-45 formally received Royal Assent Thursday morning in Canada's Parliament. The bill officially...




News published on 29 june 2015 at 12:30 and distributed by: